ENDOMETRIAL HYPERPLASIA
Clinical trials for ENDOMETRIAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Birth control IUD could treat Pre-Cancer uterine condition
Disease control TerminatedThis study tests whether the Mirena IUD, a birth control device that releases hormones, can reverse a noncancerous thickening of the uterine lining better than daily hormone pills. About 207 women with nonatypical endometrial hyperplasia will be randomly assigned to get either Mi…
Matched conditions: ENDOMETRIAL HYPERPLASIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Weight-Loss drug plus IUD aimed to save uteruses – but trial never started
Disease control TerminatedThis study planned to test whether combining the weight-loss drug semaglutide with a hormone-releasing IUD could reverse endometrial hyperplasia (a precancerous condition) in premenopausal women with obesity, allowing them to keep their uterus. The trial was withdrawn before enro…
Matched conditions: ENDOMETRIAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC